Next Article in Journal
Genetic Drivers in Sebaceous Neoplasms: A Review of Germline and Somatic Mutations and Their Role in Treatment and Management Strategies
Previous Article in Journal
Deeper Analysis to Identify the True Benefit of ICIs Immunotherapy in First-Line Treatment for Non-HER2-Positive/HER2-Negative Advanced or Metastatic Advanced or Metastatic Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJC)
 
 
Article

Article Versions Notes

Cancers 2025, 17(4), 658; https://doi.org/10.3390/cancers17040658
Action Date Notes Link
article xml file uploaded 15 February 2025 10:17 CET Original file -
article xml uploaded. 15 February 2025 10:17 CET Update -
article pdf uploaded. 15 February 2025 10:17 CET Version of Record https://www.mdpi.com/2072-6694/17/4/658/pdf-vor
article supplementary file uploaded. 15 February 2025 10:17 CET - https://www.mdpi.com/2072-6694/17/4/658#supplementary
article html file updated 15 February 2025 10:21 CET Original file -
article xml file uploaded 18 February 2025 01:41 CET Update -
article xml uploaded. 18 February 2025 01:41 CET Update https://www.mdpi.com/2072-6694/17/4/658/xml
article pdf uploaded. 18 February 2025 01:41 CET Updated version of record https://www.mdpi.com/2072-6694/17/4/658/pdf
article html file updated 18 February 2025 01:42 CET Update https://www.mdpi.com/2072-6694/17/4/658/html
Back to TopTop